Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ALXN
Tag: NASDAQ:ALXN
Analyst Upgrades – Alexion Pharmaceuticals (NASDAQ:ALXN) Stock Gets Upgraded By Evercore...
ME Staff
-
February 5, 2018
0
Analyst Upgrades – Alexion Pharmaceuticals (NASDAQ:ALXN) Stock Gets Upgraded By Evercore...
ME Staff
-
February 5, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
January 23, 2018
0
Analyst Activity – Credit Suisse Group Reiterates Outperform on Alexion Pharmaceuticals...
ME Staff
-
January 18, 2018
0
Analyst Activity – Credit Suisse Group Reiterates Buy on Alexion Pharmaceuticals...
ME Staff
-
January 18, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Results of Operations and...
ME Staff 8-k
-
October 26, 2017
0
Here’s What The Latest Approval Means For Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
-
October 25, 2017
0
Analyst Activity – Leerink Swann Reiterates Buy on Alexion Pharmaceuticals (NASDAQ:ALXN)
ME Staff
-
September 25, 2017
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
September 18, 2017
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Granted Patents For Soliris Drug
Andy Parker
-
August 16, 2017
0
1
...
3
4
5
...
7
Page 4 of 7
